Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

von Willebrand factor

Z M Ruggeri1, J Ware

  • 1Roon Research Laboratory for Arteriosclerosis and Thrombosis, Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, California 92037.

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|February 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical impact of analgesic-sedative agents and peri-operative clinical status on white matter brain injury in preterm infants following surgical NEC.

Journal of neonatal-perinatal medicine·2023
Same author

Correlation of placental pathology with the postoperative outcomes and white matter injury in preterm infants following necrotizing enterocolitis.

Journal of neonatal-perinatal medicine·2023
Same author

Dimerization of glycoprotein Ibα is not sufficient to induce platelet clearance.

Journal of thrombosis and haemostasis : JTH·2015
Same author

Interaction of von Willebrand factor with platelets and the vessel wall.

Hamostaseologie·2015
Same author

Genetic deletion of platelet glycoprotein Ib alpha but not its extracellular domain protects from atherosclerosis.

Thrombosis and haemostasis·2014
Same author

Non-myeloablative conditioning with busulfan before hematopoietic stem cell transplantation leads to phenotypic correction of murine Bernard-Soulier syndrome.

Journal of thrombosis and haemostasis : JTH·2014
Same journal

Sinomenine Regulates the TRIM32/IRF1/TRAF6 Axis to Inhibit Pyroptosis in Atopic Dermatitis.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same journal

Urolithin A Mitigates Renal Fibrosis by Promoting Fatty Acid Oxidation Through Orchestrating β-Catenin Signaling.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same journal

MiR-124 Inhibits Lipid Deposition in Mouse Liver by Targeting the Trib3/Hnf4α Pathway.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same journal

TCN2 Drives Psoriasis-Like Inflammation and Keratinocyte Hyperproliferation, Correlating With IL-1β and STAT3 Activation.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same journal

The Synthetic Melanocortin Agonist NDP-MSH Ameliorates THSD7A-Associated Membranous Nephropathy in an Active Immunization Mouse Model.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same journal

Brain-Derived Neurotrophic Factor and Associated Signaling in Kidney Diseases.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
See all related articles

Von Willebrand factor is crucial for stopping bleeding by helping platelets stick to injured vessel walls. Understanding its function may lead to new anti-thrombotic therapies.

Area of Science:

  • Biochemistry
  • Hematology
  • Molecular Biology

Background:

  • Von Willebrand factor (vWF) is a glycoprotein vital for hemostasis, mediating platelet adhesion and aggregation.
  • vWF is found in plasma, platelets, endothelial cells, and the subendothelial matrix.
  • Its role is critical under high shear stress conditions, such as in capillaries or diseased arteries.

Purpose of the Study:

  • To explore the molecular and functional biology of von Willebrand factor.
  • To investigate the mechanisms underlying vWF's role in platelet function and thrombosis.
  • To identify potential targets for novel anti-thrombotic interventions.

Main Methods:

  • This abstract does not detail specific methods.
  • The study focuses on the molecular and functional aspects of vWF.

Related Experiment Videos

  • Analysis of vWF's role in platelet aggregation and thrombus formation under shear stress.

    • Main Results:

    • Von Willebrand factor mediates platelet attachment to exposed tissues at sites of vascular injury.
    • vWF facilitates platelet aggregation, forming platelet thrombi, especially under high shear stress.
    • The protein's function is critical in preventing excessive bleeding.

    Conclusions:

    • Understanding von Willebrand factor's mechanisms and structure is key to developing new anti-thrombotic strategies.
    • vWF's involvement in thrombosis highlights its significance in cardiovascular disease.
    • Further research into vWF may yield effective therapeutic approaches.